Skip to main content

New Treatment Concepts for Insulin-Dependent Diabetes Mellitus

  • Chapter
  • 40 Accesses

Abstract

Today’s routine therapy of insulin-dependent diabetes mellitus (IDDM) is a good example of how treatment of symptoms may help the patient stay alive without curing him. The discovery of insulin by Banting and Best in 1922 and its introduction in clinical therapy lowered early diabetes lethality dramatically. Despite many attempts however, a prevention of late diabetic complications and of their contribution to common morbidity and lethality has not yet been achieved [1]. A major point of any therapy of diabetes remains whether the late-diabetic syndrome can be cured or prevented. Total endocrine-replacement therapy seems a promising attempt toward reaching this goal [2, 3]. Nevertheless, before its becoming a routine therapy many problems must be solved. Therefore, grafting either of the whole pancreas or of isolated islets of Langerhans and the related problems remain an important matter for experimental research.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. West KM (1982) Hyperglycaemia as a cause of longterm complications. In: Keen H, Jarrett RJ (eds) Complications of diabetes. Arnold, Londons, pp 13–17

    Google Scholar 

  2. Federlin K, Bretzel RG (1984) The effect of islet transplantation on complications in experimental diabetes of the rat. World J Surg 8: 169–178

    Article  PubMed  CAS  Google Scholar 

  3. Landgraf R, Landgraf-Leurs MMC, Burg D, Kampik A, Castro LA, Abendroth A, Illner W O, Land W (1986) Long-term follow-up of segmental pancreas transplantation in type 1 diabetes. Transpl. Proc. 18: 1118–1124

    Google Scholar 

  4. Gray DWR, Morris PJ (1984) Cyclosporine and pancreas transplantation. World J Surg 8: 230–235

    Article  PubMed  CAS  Google Scholar 

  5. Sutherland DWR (1981) Pancreas and islet transplantation. Diabetologia 20: 161–185

    PubMed  CAS  Google Scholar 

  6. Kamp CB, Knight MB, Sharp D W, Lacy PE, Ballinger WF (1973) Transplantation of isolated islets into the portal vein of diabetic rats. Nature 244: 447

    Article  Google Scholar 

  7. Rynasiewicz J, Sutherland DER, Kawahara K, Gorecki P, Najarian JS (1980) Cyclosporin A prolongation of segmental pancreas and islet allograft function in rats. Transpl Proc 12: 270–274

    CAS  Google Scholar 

  8. Sutherland DER (1984) Twin to twin transplantation: reversal and reenactment of pathogenesis of type I diabetes. Trans Assoc Am Physicians 97: 80–87

    PubMed  CAS  Google Scholar 

  9. Naji A, Silvers W K, Barker CF (1981) Islet transplantation in spontaneously diabetic rats. Transpl Proc 13 /1: 826–828

    CAS  Google Scholar 

  10. Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35–39

    PubMed  CAS  Google Scholar 

  11. Dibelius A, Königsberger H, Walter P, Permanetter W, Brendel W, v. Specht BU (1986) Prolonged reversal of diabetes in the rat by transplantation of allogeneic islets from a single donor and cyclosporine treatment. Transplantation 41 /4: 426–431

    Article  PubMed  CAS  Google Scholar 

  12. Lafferty KJ, Prowse, SJ (1984) Theory and practice of immunoregulation by tissue treatment prior to transplantation. World J Surg 8: 187–197

    Article  PubMed  CAS  Google Scholar 

  13. Lacy PE (1984) Experimental immunoalteration. World J Surg 8: 198–203

    Article  PubMed  CAS  Google Scholar 

  14. Bowen KM, Andrus L, Lafferty KJ (1980) Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes 29 (Suppl.): 98–104

    PubMed  Google Scholar 

  15. Rynasiewicz, JJ, Sutherland DER, Ferguson RM, Souifflet JP, Morrow CHE, Goetz FC, Najarian JS (1982) Cyclosporin A for immunosuppression: observation in rat heart, pancreas and islet allografts models and in human renal and pancreas transplantation. Diabetes 31 (Suppl) 4: 92–108

    Google Scholar 

  16. Dibelius A, Königsberger H, Permanetter W, Walter P, Brendel W, v. Specht B U (1986) Prolonged pancreatic islet allograft survival by cyclosporine compared to whole pancreas allo-graft survival. Transpl Proc 18 /5: 1167–1168

    Google Scholar 

  17. Königsberger H, Dibelius A, Permanetter W, Walter P, Brendel W, v. Specht BU (1987) Influence of postdiabetic onset time and immunosuppressive treatment on islet grafts in the spontaneous diabetic BB/W rat. Transplantation (in press)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Specht, B.U., Dibelius, A., Königsberger, H. (1987). New Treatment Concepts for Insulin-Dependent Diabetes Mellitus. In: Baethmann, A., Messmer, K. (eds) Surgical Research: Recent Concepts and Results. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73097-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73097-9_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73099-3

  • Online ISBN: 978-3-642-73097-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics